Want to see EBS full AI Analyst Report?
Emergent Biosolutions (EBS) Q3 2026 Earnings Report
EBS Q3 2026 EPS Results
- Actual EPS
- -$0.36
- Consensus EPS
- -$0.39
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- $1.06
EBS Q3 2026 Revenue Results
- Actual Revenue
- $110.00M
- Expected Revenue
- $123.22M
- Beat/Miss
- Missed by -$13.22M
- YoY Revenue Growth
- -52.40%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/02/2026
- Time
- After Close
- Conference Call
- Monday, November 2, 2026
EBS Upcoming Earnings
Emergent Biosolutions's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
EBS Q3 2026 Earnings Call
0:00 / 0:00
Q3 2026 Earnings Slide Deck
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
EBS Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | -0.08- | -0.43 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.39-0.36 | 1.06 | -133.96% (-1.42) | |
| Aug 05, 2026 | 2026 (Q2) | -0.090.60 | 0.16 | 275.00% (+0.44) | |
| Apr 30, 2026 | 2026 (Q1) | -0.250.21 | 0.71 | -70.42% (-0.50) | |
| Feb 26, 2026 | 2025 (Q4) | 0.11-0.43 | 0.05 | -960.00% (-0.48) | |
| Oct 29, 2025 | 2025 (Q3) | -0.121.06 | 1.37 | -22.63% (-0.31) | |
| Aug 06, 2025 | 2025 (Q2) | -0.490.16 | -2.32 | 106.90% (+2.48) | |
| May 07, 2025 | 2025 (Q1) | 0.440.71 | 0.59 | 20.34% (+0.12) | |
| Mar 03, 2025 | 2024 (Q4) | -0.500.05 | -0.77 | 106.49% (+0.82) | |
| Nov 06, 2024 | 2024 (Q3) | 0.101.37 | -0.54 | 353.70% (+1.91) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
